NPPA Retail Price Fixation for Cholecalciferol Oral Solution under DPCO, 2013

May 13, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA), on May 12, 2026, under Para 5 of the Drugs (Prices Control) Order, 2013, issued a retail price fixation order based on September 2025 data for the formulation “Each 5 ml Contains: Cholecalciferol IP 60000 IU (In Nano Droplet Form) Oral Solution” manufactured by M/s Tirupati Medicare Ltd. and marketed by M/s Intas Pharmaceuticals Ltd. The price fixation pertains to File No. 5124.

As per the notification, the worked-out retail price of the formulation was determined at ₹15.88 per ml excluding GST. However, the claimed price submitted by the company was ₹14.91 per ml excluding GST. After examination, the NPPA proposed the retail price at ₹14.91 per ml excluding GST under the provisions of DPCO, 2013.

The notified retail price will apply to the specified formulation and manufacturers/marketers concerned, subject to the applicable provisions relating to GST and compliance under the Drugs (Prices Control) Order, 2013. 

[F. No. 19(5124)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT